Basu P, Maddula A, Nelson T, Prasoon P, Winter M, Herzog H
Anesthesiology. 2024; 141(5):946-968.
PMID: 39121458
PMC: 11461131.
DOI: 10.1097/ALN.0000000000005184.
Kloock S, Haerting N, Herzog G, Oertel M, Geiger N, Geier A
Nutrients. 2024; 16(6).
PMID: 38542814
PMC: 10974407.
DOI: 10.3390/nu16060904.
Xu L, Zhang J, Yang H, Cao C, Fang R, Liu P
Front Psychiatry. 2024; 15:1257911.
PMID: 38487579
PMC: 10937445.
DOI: 10.3389/fpsyt.2024.1257911.
Sharma A, Ren X, Zhang H, Pandey G
Prog Neuropsychopharmacol Biol Psychiatry. 2021; 112:110428.
PMID: 34411658
PMC: 8489679.
DOI: 10.1016/j.pnpbp.2021.110428.
Mogami S, Arita R, Nahata M, Fujitsuka N, Takayama S, Ishii T
Evid Based Complement Alternat Med. 2020; 2020:3797219.
PMID: 32089720
PMC: 7013301.
DOI: 10.1155/2020/3797219.
Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice.
Yamada C, Mogami S, Kanno H, Hattori T
Mol Neurobiol. 2018; 55(9):7555-7566.
PMID: 29429048
PMC: 6096978.
DOI: 10.1007/s12035-018-0931-1.
Neuropeptide Y in Alcohol Addiction and Affective Disorders.
Thorsell A, Mathe A
Front Endocrinol (Lausanne). 2017; 8:178.
PMID: 28824541
PMC: 5534438.
DOI: 10.3389/fendo.2017.00178.
Neuropeptide Y input to the rat basolateral amygdala complex and modulation by conditioned fear.
Leitermann R, Rostkowski A, Urban J
J Comp Neurol. 2016; 524(12):2418-39.
PMID: 26779765
PMC: 4900924.
DOI: 10.1002/cne.23960.
Structure and function of the amygdaloid NPY system: NPY Y2 receptors regulate excitatory and inhibitory synaptic transmission in the centromedial amygdala.
Wood J, Verma D, Lach G, Bonaventure P, Herzog H, Sperk G
Brain Struct Funct. 2015; 221(7):3373-91.
PMID: 26365505
PMC: 4696156.
DOI: 10.1007/s00429-015-1107-7.
Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models.
Samsom J, Wong A
Front Psychiatry. 2015; 6:13.
PMID: 25762938
PMC: 4332163.
DOI: 10.3389/fpsyt.2015.00013.
Effects of sex and deletion of neuropeptide Y2 receptors from GABAergic neurons on affective and alcohol drinking behaviors in mice.
McCall N, Sprow G, Delpire E, Thiele T, Kash T, Pleil K
Front Integr Neurosci. 2014; 7:100.
PMID: 24399943
PMC: 3872329.
DOI: 10.3389/fnint.2013.00100.
Ligands of the neuropeptide Y Y2 receptor.
Mittapalli G, Roberts E
Bioorg Med Chem Lett. 2013; 24(2):430-41.
PMID: 24365162
PMC: 4672871.
DOI: 10.1016/j.bmcl.2013.11.061.
Administration of the Y2 receptor agonist PYY3-36 in mice induces multiple behavioral changes relevant to schizophrenia.
Stadlbauer U, Langhans W, Meyer U
Neuropsychopharmacology. 2013; 38(12):2446-55.
PMID: 23748226
PMC: 3799064.
DOI: 10.1038/npp.2013.146.
Neuropeptide Y, peptide YY and pancreatic polypeptide in the gut-brain axis.
Holzer P, Reichmann F, Farzi A
Neuropeptides. 2012; 46(6):261-74.
PMID: 22979996
PMC: 3516703.
DOI: 10.1016/j.npep.2012.08.005.
Neuropeptide Y and posttraumatic stress disorder.
Sah R, Geracioti T
Mol Psychiatry. 2012; 18(6):646-55.
PMID: 22801411
PMC: 4749915.
DOI: 10.1038/mp.2012.101.
NPY controls fear conditioning and fear extinction by combined action on Y₁ and Y₂ receptors.
Verma D, Tasan R, Herzog H, Sperk G
Br J Pharmacol. 2012; 166(4):1461-73.
PMID: 22289084
PMC: 3401902.
DOI: 10.1111/j.1476-5381.2012.01872.x.
Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide Y.
Painsipp E, Herzog H, Sperk G, Holzer P
Br J Pharmacol. 2011; 163(6):1302-14.
PMID: 21410462
PMC: 3144542.
DOI: 10.1111/j.1476-5381.2011.01326.x.
Therapeutic potential of neuropeptide Y (NPY) receptor ligands.
Brothers S, Wahlestedt C
EMBO Mol Med. 2010; 2(11):429-39.
PMID: 20972986
PMC: 3394504.
DOI: 10.1002/emmm.201000100.
The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression.
Tasan R, Nguyen N, Weger S, Sartori S, Singewald N, Heilbronn R
J Neurosci. 2010; 30(18):6282-90.
PMID: 20445054
PMC: 3073168.
DOI: 10.1523/JNEUROSCI.0430-10.2010.
In vitro and in vivo characterization of JNJ-31020028 (N-(4-{4-[2-(diethylamino)-2-oxo-1-phenylethyl]piperazin-1-yl}-3-fluorophenyl)-2-pyridin-3-ylbenzamide), a selective brain penetrant small molecule antagonist of the neuropeptide Y Y(2) receptor.
Shoblock J, Welty N, Nepomuceno D, Lord B, Aluisio L, Fraser I
Psychopharmacology (Berl). 2009; 208(2):265-77.
PMID: 19953226
DOI: 10.1007/s00213-009-1726-x.